The Effects of 12-months of Denosumab on Bone Density in Prevalent Kidney Transplant Recipients

Conditions:   Osteoporosis;   Renal Osteodystrophy;   Kidney Transplant; Complications Interventions:   Drug: Denosumab Inj 60 mg/ml;   Other: Placebo Sponsor:   Thomas Nickolas, MD MS Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials